Cointime reports: China’s national medical insurance platform released its annual drug procurement report on November 14 in Suzhou, Jiangsu. Since the medical insurance list began dynamic adjustments in 2018, the cumulative number of negotiated drugs reached 530 by 2024. Compared with 2024 data, 84.2% of negotiated drugs achieved growth in both procurement value and volume in 2025.
84.2% of Negotiated Drugs in China’s 2025 Medical Insurance List Saw Both Purchase Value and Volume Growth
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
24m ago
UBS Global Wealth Management Forecasts S&P 500 at 8,200 by End-2027
45m ago
Tencent Q3 2026 Revenue Rises 8% to RMB 207.3 Billion
48m ago
Onshore yuan closes at 6.6653 per dollar, up 2 pips
1h ago
Hong Kong’s Hang Seng closes down 0.91%; Zhipu jumps over 9%
1h ago
Goldman Sachs Forecasts Gold May Return to $5,600 by Late 2028
2h ago
Dollar Holds Near 19-Month High on Fed Rate Hike Expectations